Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FTX transcript, XIST regulator (non-protein coding) is a long non-coding RNA (lncRNA) gene located upstream of XIST within the X-inactivation center (XIC) on the X chromosome[4][5]. FTX is a member of the non-coding RNA family and is involved in the epigenetic regulation of gene expression, specifically serving as a positive regulator of XIST and X chromosome inactivation (XCI) in mice[1][3][5]. In humans, FTX contains regulatory elements that interact with the XIST promoter region, but functional studies have shown that FTX does not play a major role in regulating XIST expression in humans, in contrast to the mouse ortholog[3]. FTX's involvement in XCI links it to processes such as cell differentiation, dosage compensation, and potentially cancer when X-linked gene regulation is disrupted[2][5]. FTX does not code for a protein and is not considered a therapeutic target such as a receptor, enzyme, or transporter[^5]. There are currently no known drugs that directly target FTX, nor is it used as a clinical biomarker or has associated therapeutic safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FTX transcript, XIST regulator (non-protein coding) (FTX).